Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.

Nanomaterials (Basel) · 2017 · PMC5746925 · PMID 29292780

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Figure 2 E shows an increasing trend of signal in correlation with the increasing ninhydrin amount up to 32 μg per reaction.

also in 63,971 other papers

a decreasing trendno p-value reported

Figure 5 B(b) illustrates a decreasing trend of the doxorubicin fluorescence with the higher concentration of TPP.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.